Cellectis Commercial Paper Liability (Quarterly) Analysis

Cellectis SA (CLLS)

3.96 +0.06 (+1.54%) USD | NASDAQ | Feb 23, 16:00

3.96 0.00 (0.00%) After-Hours: 17:20

View Commercial Paper Liability (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	--
Ascendis Pharma A/S	--
Akari Therapeutics Plc	--
Biodexa Pharmaceuticals Plc	--